Table 3.
Identified metabolite | Formula | Adducts | RT (min) | Ion (m/z) | Mass error (ppm) | VIP | Fold change | AUC | P | FDR |
---|---|---|---|---|---|---|---|---|---|---|
Alloxan | C4H2N2O4 | M−H | 15.87 | 140.99 | 1.97 | 1.01 | 1.27 | 0.89 | <0.01 | 0.047 |
12,13-DHOME | C18H34O4 | M−H | 10.17 | 313.24 | 1.47 | 0.92 | −1.43 | 0.89 | <0.01 | 0.047 |
Kynurenic acid | C10H7NO3 | M−H | 2.19 | 188.03 | 3.25 | 1.86 | −1.96 | 0.89 | 0.01 | 0.047 |
Tauroursodeoxycholic acid | C26H45NO6S | M−H | 1.80 | 498.29 | 0.73 | 2.51 | −6.74 | 0.84 | 0.01 | 0.047 |
Celastrol | C29H38O4 | M−H | 12.29 | 449.27 | 2.25 | 0.71 | 1.40 | 0.89 | 0.01 | 0.047 |
DG(22:0/20:3(5Z,8Z,11Z)/0:0) | C45H82O5 | M + H | 14.63 | 703.62 | 3.66 | 1.57 | 2.02 | 0.86 | 0.01 | 0.047 |
Pentadecanoic acid2 | C15H30O2 | M−H | 13.03 | 241.22 | 1.06 | 1.26 | −1.70 | 0.86 | 0.01 | 0.047 |
Malonyl-L-carnitine | C10H17NO6 | M−H | 1.95 | 246.10 | 0.40 | 1.05 | 1.30 | 0.86 | 0.01 | 0.047 |
Pterin | C6H5N5O | M−H | 13.03 | 162.04 | 2.64 | 1.24 | 1.48 | 0.84 | 0.02 | 0.047 |
N1-(5-Phospho-a-D-ribosyl)-5,6-dimethylbenzimidazole | C14H19N2O7P | M + H | 8.67 | 359.09 | 2.19 | 0.67 | 1.76 | 0.86 | 0.02 | 0.047 |
Pteroyl-D-glutamic acid | C20H23N7O7 | M + H | 10.78 | 474.17 | 1.47 | 0.70 | 1.17 | 0.83 | 0.02 | 0.047 |
N-Acryloylglycine | C5H7NO3 | M + H | 12.40 | 130.05 | 4.82 | 0.67 | 1.13 | 0.84 | 0.02 | 0.047 |
Eicosenoic acid2 | C20H38O2 | M−H | 14.59 | 309.28 | 0.99 | 1.00 | −1.62 | 0.81 | 0.02 | 0.047 |
Pyroglutamic acid | C5H7NO3 | M−H | 13.28 | 128.03 | 4.73 | 1.43 | 1.62 | 0.86 | 0.02 | 0.047 |
All-trans-heptaprenyl diphosphate | C28H49N3O16 | M + H | 10.46 | 655.38 | 3.81 | 1.31 | −1.51 | 0.83 | 0.03 | 0.047 |
5-Dodecenoic acid | C12H22O2 | M + H | 10.35 | 199.17 | 4.97 | 0.97 | −1.38 | 0.80 | 0.03 | 0.047 |
3-Oxooctadecanoic acid | C18H34O3 | M + H | 10.35 | 299.26 | 2.80 | 0.82 | −1.33 | 0.81 | 0.03 | 0.047 |
Androsterone sulfate | C19H30O5S | M + H | 8.67 | 371.19 | 2.75 | 0.86 | 1.23 | 0.83 | 0.03 | 0.047 |
DG(18:3(9Z,12Z,15Z)/15:0/0:0) | C36H64O5 | M + H | 17.45 | 577.48 | 4.31 | 1.04 | 1.43 | 0.88 | 0.03 | 0.047 |
Linoleic acid* | C18H32O2 | M + H | 10.35 | 281.25 | 2.59 | 0.97 | −1.21 | 0.81 | 0.03 | 0.047 |
20-Carboxyleukotriene B4 | C20H30O6 | M + H | 14.26 | 367.21 | 1.21 | 0.75 | −1.14 | 0.75 | 0.03 | 0.047 |
Harderoporphyrin | C35H36N4O6 | M + H | 12.11 | 609.27 | 3.55 | 1.71 | −2.56 | 0.78 | 0.03 | 0.047 |
Sebacic acid | C10H18O4 | M−H | 7.31 | 201.11 | 2.59 | 0.74 | 1.38 | 0.80 | 0.03 | 0.047 |
Oleamide | C18H35NO | M + H | 15.07 | 282.28 | 3.66 | 0.64 | 1.13 | 0.83 | 0.04 | 0.047 |
Glycocholic acid | C26H43NO6 | M−H | 5.52 | 464.30 | 0.96 | 1.86 | −1.94 | 0.78 | 0.04 | 0.047 |
Chitin | C28H49N3O16 | M + H | 10.57 | 684.32 | 3.56 | 0.63 | 1.41 | 0.80 | 0.04 | 0.047 |
Imidazole-4-acetaldehyde | C5H6N2O | M−H | 1.36 | 109.04 | 3.19 | 0.62 | 1.13 | 0.79 | 0.04 | 0.047 |
Vaccenic acid | C18H34O2 | M−H | 13.39 | 281.25 | 0.16 | 1.01 | −1.37 | 0.80 | 0.04 | 0.047 |
Calcitroic acid | C23H34O4 | M + H | 11.20 | 375.25 | 2.29 | 0.56 | 1.13 | 0.80 | 0.04 | 0.047 |
Alpha-Linolenic acid2 | C18H30O2 | M + H | 9.80 | 279.23 | 1.08 | 1.09 | −2.23 | 0.80 | 0.04 | 0.047 |
12a-Hydroxy-3-oxo-choladienic acid | C24H34O4 | M−H | 11.59 | 385.24 | 1.49 | 1.26 | −1.35 | 0.83 | 0.04 | 0.047 |
5-Sulfosalicylic acid | C7H6O6S | M + H | 13.46 | 219.00 | 1.77 | 1.14 | 1.51 | 0.75 | 0.05 | 0.049 |
3-Octenedioic acid | C8H12O4 | M−H | 9.52 | 171.07 | 2.13 | 1.05 | 1.50 | 0.77 | 0.05 | 0.049 |
RT, retention time; VIP, value of importance in projection; Fold changes comparing the greatest average daily gain steers (n = 8) with the least average daily gain steers (n = 8) on ruminal fluid metabolites; AUC, area under the curve; P, treatment effect result from t-test; FDR, false discovery rate p-adjustment.
2Metabolites were quantified by liquid chromatogram tandem mass spectrometry using isotope dilution.